Target RWE
Joy Peter is the Vice President of Evidence Solutions at Target RWE. Prior to her current role, Joy served as Associate Director of the HCV-TARGET Network at the University of Florida (UF) where she worked with co-founder Dr. Fried to develop a large international network of 50+ academic and community investigators partnered with the FDA, HCV patient advocacy groups to follow outcomes and rapidly inform clinical practice in patients treated for HCV. Joy helped design several other innovative studies within HCV-TARGET including a large, pragmatic PCORI study, multiple post-marketing commitment and post authorization studies as well as protocols to pair clinical data to biospecimens.
Outside of Target RWE, Joy’s expertise includes more than 20 years of clinical research experience as a nurse with subject matter expertise in liver disease and broad knowledge from her role as Associate Director of Hepatology Clinical Research at UF since 2002.
This person is not in any offices
Target RWE
As the industry’s best-in-class, complete real world evidence (RWE) solution, Target RWE is a distinctly collaborative enterprise that unifies real world data (RWD) sets and advanced RWE analytics in an integrated community, shifting the paradigm in healthcare for how decisions are made to improve lives. Target RWE sources unique, connected data sets across multiple therapeutic areas representing granular data from diverse patients in academic and community settings. Their rigorous, interactive, and advanced RWE analytics extract deep insights from RWD to answer important questions in healthcare. Target RWE brings together the brightest minds in healthcare through an unmatched community of key opinion leaders, patients, and healthcare stakeholders in a collaborative and dynamic model.